Evoq Remedies IPO listing price is ₹ 23.75, issue price is ₹ 27.00, and currently trading at ₹ 4.60 as on June 12, 2025. Evoq Remedies IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Evoq Remedies IPO is a Fixed Price listing on BSE SME exchange. The company is based in Ahmedabad and caters to Pharmaceutical sector. Swastika Investmart is the merchant banker of Evoq Remedies IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 24th February 2022.
Evoq Remedies IPO offer price is ₹ 27.00 and got listed at ₹ 23.75. Read Evoq Remedies IPO details mentioned above.The IPO of Evoq Remedies Limited was listed on 30th March 2022. As of today, Evoq Remedies IPO is trading at ₹ 4.60, compared to the previous day’s close of ₹ 4.51. Read the report above for detailed IPO performance.
The issue price of Evoq Remedies IPO was ₹ 27.00 per equity share.
Evoq Remedies IPO was listed at ₹23.75 on the stock exchange on 30th March 2022. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of June 12, 2025, the current market price of Evoq Remedies IPO is ₹ 4.60.
The 52-week high for Evoq Remedies IPO is [●], while the 52-week low is [●]. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Evoq Remedies IPO listed at ₹ 23.75 against the issue price of ₹ 27.00 per equity share, showing a listing day gain/loss of -3.25 (-12.04%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Evoq Remedies IPO stock moved from its listing price of ₹ 23.75 to the current price of ₹4.60 per equity share, reflecting a change of -80.63% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Evoq Remedies IPO issue date of 30th March 2022 and CMP of ₹4.60, the estimated CAGR is approximately -42.35%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Evoq Remedies IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Evoq Remedies Financial Review Page
Merchant Banker(s) of Evoq Remedies IPO: Swastika Investmart Limited
Evoq Remedies IPO subscription was 1.67 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Evoq Remedies IPO listed at a listing price of 23.75 against the offer price of 27.00.
The current market price of Evoq Remedies is 4.60.
Why Us?